France· FR:62428328
BENAZEPRIL HYDROCHLOROTHIAZIDE EG 10 mg/12,5 mg, comprimé pelliculé sécable
A medicinal product containing hydrochlorothiazide + chlorhydrate de bénazépril, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HYDROCHLOROTHIAZIDE + CHLORHYDRATE DE BÉNAZÉPRIL
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400939028033plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)EUR 3.64
- cip133400939028262plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 90 comprimé(s)EUR 10.53
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrochlorothiazide + chlorhydrate de bénazépril in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesbenazepril hydrochloride and hydrochlorothiazidePadagis US LLC
- GermanyBenazeplusStadapharm Gmbh
- ItalyBENAZEPRIL IDROCLOROTIAZIDE EGEG S.P.A.
- SpainCIBADREX 10 mg / 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAMeda Pharma S.L.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Benazeplus, Benazepril Comp 1 A Pharma
- Greece · Cibadrex
- Hungary · Lotensin Hct
- Italy · Benazepril Idroclorotiazide Eg, Benazepril Idroclorotiazide Sandoz
- Netherlands · Benazepril Hcl/Hydrochloorthiazide Hexal Ag
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/020d5d74-253d-4f73-a4be-116a17124c82 GET /v1/drugs/020d5d74-253d-4f73-a4be-116a17124c82?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62428328",
"date_amm": "2008-10-10",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "HYDROCHLOROTHIAZIDE + CHLORHYDRATE DE BÉNAZÉPRIL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about hydrochlorothiazide + chlorhydrate de bénazépril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.